RBM20 and familial dilated cardiomyopathy: In a hypothesis-driven approach to rescuing the DCM-related heterozygous RBM20 p.P633L variant, all-trans retinoic acid (ATRA) was found to stimulate the transcriptional upregulation of RBM20, which compensated for cellular deficits in splicing, calcium handling, and contractility.